))
Interview with Dr. Paul Stoffels, Johnson & Johnson
Manage episode 299555218 series 2872650
Sisällön tarjoaa Maria C. Freire, Ph.D. and Maria C. Freire. Maria C. Freire, Ph.D. and Maria C. Freire tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Listen in as Dr. Maria Freire explores the work of Dr. Paul Stoffels, Johnson & Johnson’s Vice Chairman of the Executive Committee and Chief Scientific Officer, and his team as they have worked since April 2020 developing COVID-19 vaccines and monitoring emerging variants.
Along with Dr. Francis Collins, Director of NIH, Dr. Stoffels co-chairs Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV), the historic public-private partnership created to combat COVID-19 on all fronts.
7 jaksoa
Jaa
